Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease.

Ramsey Najm1,2, Emily A Jones1,3, Yadong Huang4,5,6,7,8

  • 1Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.

Molecular Neurodegeneration
|June 13, 2019
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human milk and total milk intakes of mixed fed infants: a cross-sectional study of infants aged 7-10 months.

European journal of nutrition·2026
Same author

Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis.

Nature aging·2026
Same author

Neuronal APOE4 alone is sufficient to drive tau pathology, neurodegeneration, and neuroinflammation in an Alzheimer's disease mouse model.

bioRxiv : the preprint server for biology·2025
Same author

Household food insecurity, nutrient intakes and BMI in New Zealand infants.

Public health nutrition·2025
Same author

A Comparative Trial of Occupational Therapy Using Ayres Sensory Integration and Applied Behavior Analysis Interventions for Autistic Children.

Autism research : official journal of the International Society for Autism Research·2025
Same author

Frequent Use of Baby Food Pouches in Infants and Young Children and Associations with Energy Intake and BMI: An Observational Study.

Nutrients·2024

Apolipoprotein E4 (apoE4) worsens Alzheimer's disease by harming specific brain cells. This leads to network dysfunction and cognitive decline, offering a new understanding of AD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Apolipoprotein E4 (apoE4) is a key genetic risk factor for Alzheimer's disease (AD).
  • Mechanisms linking apoE4 to cognitive decline remain incompletely understood.
  • Human induced pluripotent stem cell (hiPSC) and in vivo electrophysiology models are advancing research.

Purpose of the Study:

  • To review apoE4's detrimental effects in the central nervous system (CNS).
  • To focus on apoE4's impact on specific neuronal subtypes, particularly GABAergic interneurons.
  • To elucidate the pathway from apoE4-induced interneuron loss to cognitive deficits in AD.

Main Methods:

  • Literature review of studies on apoE4 and neurological disease.
  • Focus on hiPSC modeling and in vivo electrophysiological data.
Keywords:
Alzheimer’s diseaseApolipoprotein EGABAergic interneuronHyperexcitabilityInhibitory networkSelective vulnerabilityTau

Related Experiment Videos

  • Analysis of apoE4's effects on GABAergic interneurons and neural networks.

    • Main Results:

    • ApoE4 selectively causes neurotoxicity in hippocampal GABAergic interneurons.
    • Loss of these interneurons disrupts the brain's inhibitory network.
    • This disruption leads to hyperexcitability and cognitive deficits characteristic of AD.

    Conclusions:

    • ApoE4-mediated GABAergic interneuron loss is a critical mechanism in AD.
    • A proposed model links aging/stress, apoE4, tau, interneuron death, network hyperexcitability, and cognitive decline.
    • Targeting apoE4's effects on interneurons may offer therapeutic strategies for AD.